HYLG:NYE-Global X Funds - Global X Health Care Covered Call & Growth ETF (USD)

ETF | Others |

Last Closing

USD 26.12

Change

-0.04 (-0.17)%

Market Cap

N/A

Volume

30.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

-0.05 (-0.23%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.08 (+0.14%)

USD 35.71B
DFAC Dimensional U.S. Core Equity 2..

-0.02 (-0.06%)

USD 31.07B
DTB DTE Energy Company 2020 Series

+0.11 (+0.50%)

USD 26.58B
JPST JPMorgan Ultra-Short Income ET..

+0.01 (+0.02%)

USD 25.99B
SGOV iShares® 0-3 Month Treasury B..

N/A

USD 25.64B
GBTC Grayscale Bitcoin Trust (BTC)

-1.20 (-2.44%)

USD 23.75B
AVUV Avantis® U.S. Small Cap Value..

-0.35 (-0.37%)

USD 13.60B
JAAA Janus Detroit Street Trust - J..

+0.01 (+0.02%)

USD 12.46B
DFUV Dimensional US Marketwide Valu..

-0.01 (-0.02%)

USD 11.30B

ETFs Containing HYLG

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.42% 42% F 45% F
Dividend Return 3.33% 63% D 58% F
Total Return 9.75% 47% F 46% F
Trailing 12 Months  
Capital Gain 8.81% 30% F 32% F
Dividend Return 6.63% 85% B 77% C+
Total Return 15.44% 37% F 37% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.25% N/A N/A 43% F
Dividend Return 3.70% N/A N/A 43% F
Total Return 2.45% N/A N/A 53% F
Risk Return Profile  
Volatility (Standard Deviation) 5.30% N/A N/A 90% A-
Risk Adjusted Return 69.85% N/A N/A 83% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike